Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · IEX Real-Time Price · USD
234.19
+0.26 (0.11%)
Apr 24, 2024, 4:00 PM EDT - Market closed
Company Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.
The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Inspire Medical Systems, Inc.
Country | United States |
Founded | 2007 |
IPO Date | May 3, 2018 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 1,011 |
CEO | Timothy P. Herbert |
Contact Details
Address: 5500 Wayzata Blvd, Suite 1600 Golden Valley, Minnesota 55416 United States | |
Phone | 763-957-5037 |
Website | inspiresleep.com |
Stock Details
Ticker Symbol | INSP |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001609550 |
CUSIP Number | 457730109 |
ISIN Number | US4577301090 |
Employer ID | 26-1377674 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Timothy P. Herbert | Chief Executive Officer, President and Director |
Richard J. Buchholz | Chief Financial Officer |
Philip J. Ebeling | Chief Operating Officer |
Randall A. Ban | Chief Commercial Officer |
Dr. Charisse Y. Sparks FAAOS, M.D. | Chief Medical Officer |
Carlton W. Weatherby | Chief Strategy Officer |
John C. Rondoni | Chief Technology Officer |
Ezgi Yagci | Vice President of Investor Relations |
Bryan K. Phillips | Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary |
Steven L. Jandrich | Vice President of Human Resources |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 17, 2024 | 144 | Filing |
Apr 1, 2024 | 144 | Filing |
Apr 1, 2024 | 144 | Filing |
Apr 1, 2024 | 144 | Filing |
Mar 25, 2024 | 144 | Filing |
Mar 22, 2024 | 144 | Filing |
Mar 19, 2024 | ARS | Filing |
Mar 19, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Mar 19, 2024 | DEF 14A | Other definitive proxy statements |
Mar 18, 2024 | 144 | Filing |